Onderneming Pharmala Biotech Holdings Inc.
Aandelen
MDMA
CA71719L1067
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,19 CAD | -2,56% | -9,52% | +35,71% |
05/04 | PharmAla Biotech geeft Australische update | MT |
27/03 | Pharmala Biotech Holdings Inc. Toelating verleend voor Ala-002 Samenstelling door US Patent and Trademark Office | CI |
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Engineering-grade (Non-GMP) Product
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +581,44% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +581,44% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nick Kadysh
CEO | Chief Executive Officer | 38 | 21-03-21 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | 22-03-21 |
Harpreet Kaur
CTO | Chief Tech/Sci/R&D Officer | - | - |
Shane Morris
COO | Chief Operating Officer | 49 | 22-03-21 |
David Purcell
SAM | Sales & Marketing | - | 14-03-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kevin Roy
BRD | Director/Board Member | - | 04-06-22 |
Director/Board Member | 62 | 21-03-21 | |
Jodi Butts
CHM | Chairman | 51 | 21-03-21 |
Nick Kadysh
CEO | Chief Executive Officer | 38 | 21-03-21 |
Perry Tsergas
BRD | Director/Board Member | 39 | 21-03-21 |
Fraser MacDonald
BRD | Director/Board Member | 38 | 21-03-21 |
Harriet de Wit
BRD | Director/Board Member | 76 | 21-03-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 86 907 552 | 81 657 052 ( 93,96 %) | 0 | 93,96 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,71% | 12,32 mln. | |
-1,65% | 104 mld. | |
+6,75% | 97,47 mld. | |
+5,71% | 22,25 mld. | |
-12,60% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-10,17% | 16,36 mld. | |
+6,12% | 14,39 mld. | |
+35,47% | 12,37 mld. |
- Beurs
- Aandelen
- Koers MDMA
- Onderneming Pharmala Biotech Holdings Inc.